This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Novak, J. F. Articles by Nishimoto, S. K. Search for Related Content PubMed PubMed Citation Articles by Novak, J. F. Articles by Nishimoto, S. K.

A Plasmin-derived Hexapeptide from the Carboxyl End of Osteocalcin Counteracts Oxytocin-mediated Growth of Inhibition of Osteosarcoma Cells¹

Department of Biology, Bucknell University, Lewisburg, Pennsylvania 17837 [J. F. N., M. B. J., M. I. C., J. A. N.]; Department of Biomedical Sciences and Oncology, University of Turin, Turin, Italy 10126 [P. C., G. B.]; and Department of Biochemistry, University of Tennessee, Memphis, Tennessee 38163 [S. K. N.]

We have previously described the presence of the functional plasminogen activator system on the surfaces of bone neoplastic cells and the fact that plasmin specifically cleaves bone matrix protein osteocalcin (OC). The cleavage of OC to NH₂-midterminal (1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44) and COOH-terminal RFYGPV hexapeptide (44 45 46 47 48 49) proceeds with detachment of both products from bone mineral. Because the sequence of OC-derived hexapeptide (HP) is nearly identical to the E2 region of the oxytocin receptor (OTR), we set out to ascertain whether the HP interferes with the osteosarcoma (OS)-associated oxytocin (OT) system. We documented the presence and functional activity of OTRs in several OS cells by means of (a) OT-mediated inhibition of OS growth; (b) expression of OTR mRNA by means of reverse transcription-PCR; (c) immunofluorescence staining with IF3 monoclonal antibody specific for human OTR; and (d) saturation binding and Scatchard analysis of OT binding to the receptors of isolated membranes or intact OS cells. Although we could not demonstrate direct binding of HP to OT, the presence of HP in cultures of OS cells antagonizes the inhibitory effect of OT on these cells. Additionally, in competitive binding assays, the HP effectively competes with binding of OT to its cognate receptors. The results indicate the existence of an OTR/OT system in tumor cells of bone origin. Suggested plasminogen activator-OC-OTR/OT interactions may have an effect on the regulation of cell proliferation within the bone tissue as well as properties of the extracellular matrix surrounding the tumor foci in the bone.

This article has been cited by other articles:

				Y. Suzuki, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, S. Nomura, M. Tsujimoto, and S. Mizutani Possible Role of Placental Leucine Aminopeptidase in the Antiproliferative Effect of Oxytocin in Human Endometrial Adenocarcinoma Clin. Cancer Res., April 1, 2003; 9(4): 1528 - 1534. [Abstract] [Full Text] [PDF]

				G. Bussolati, M. Chinol, B. Chini, A. Nacca, P. Cassoni, and G. Paganelli 111In-labeled 1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic Acid-Lys8-Vasotocin: A New Powerful Radioligand for Oxytocin Receptor-expressing Tumors Cancer Res., June 1, 2001; 61(11): 4393 - 4397. [Abstract] [Full Text] [PDF]

				G. Bussolati and P. Cassoni Editorial: The Oxytocin/Oxytocin Receptor System--Expect the Unexpected Endocrinology, April 1, 2001; 142(4): 1377 - 1379. [Full Text]

				P. Cassoni, A. Sapino, L. Munaron, S. Deaglio, B. Chini, A. Graziani, A. Ahmed, and G. Bussolati Activation of Functional Oxytocin Receptors Stimulates Cell Proliferation in Human Trophoblast and Choriocarcinoma Cell Lines Endocrinology, March 1, 2001; 142(3): 1130 - 1136. [Abstract] [Full Text] [PDF]